ABBV sold $10.1M of RETA stock yesterday: https://www.sec.gov/Archives/edgar/data/1358762/000117911017005277/xslF345X03/edgar.xml ABBV still owns $27.0M worth of RETA stock (1.19M shares) at the current market price. ABBV’s equity stake in RETA is the result of a 2010 deal for the ex-US rights to Bardoxolone (#msg-54747777).